Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Ayrmid, Incyte, Junshi, Ocular.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ceribell, MMI.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ascentage, Biogen, Celltrion, Cosmo, Iaso, Innovent.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Ascentage, BMS, Vanda.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Resmed.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: J&D, Eli Lilly, Merakris, Uniqure.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Atraverse, Cardiawave, Medtronic.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Aobiome, Celltrion, Polypid.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Axogen, Catalyst Orthoscience, Insulet, MED-EL, Medtronic, Wingderm Electro-optics.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Amneal, Arrowhead, Astrazeneca, Biofrontera, Birchbiomed, Cosmo, Glenmark, Ionis, Nrx, Samsung Bioepsis, Sangamo.